⌘K

Home/Filings/4/0001345281-20-000003

4//SEC Filing

KAY CHRISTINA 4

Accession 0001345281-20-000003

CIK 0001016504other

View on SEC.gov Company Profile

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 4:40 PM ET

Size

5.4 KB

Accession

0001345281-20-000003

Insider Transaction Report

Form 4

Period: 2020-11-04

INTEGRATED BIOPHARMA INCinbp

DirectorExecutive Vice President

Transactions

Award
Stock Option (right to buy)
2020-11-04+100,000→ 100,000 total
Exercise: $0.65Exp: 2030-11-04→ Common Stock (100,000 underlying)

Footnotes (1)

[F1]The option vests in three equal annual installments beginning on November 4, 2021.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

INTEGRATED BIOPHARMA INC

CIK 0001016504

Entity typeother

Related Parties

1

filerCIK 0001064901

Filing Metadata

Form type: 4
Filed: Nov 19, 7:00 PM ET
Accepted: Nov 20, 4:40 PM ET
Size: 5.4 KB

View on SEC.gov